ANDA 205257, held by Mylan. Tramadol Hydrochloride.
As of Nov 16, 2026, ANDA 205257 (Tramadol Hydrochloride), held by Mylan, was first approved by FDA on Dec 22, 2015, with 13 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 22, 2015 | Original application | Approved |
| Tramadol Hydrochloride100MG · tablet, extended release;oral | Tramadol Hydrochloride | Discontinued |
| Tramadol Hydrochloride200MG · tablet, extended release;oral | Tramadol Hydrochloride | Discontinued |
| Tramadol Hydrochloride300MG · tablet, extended release;oral | Tramadol Hydrochloride | Discontinued |
| Jun 18, 2026 | Supplement 16REMS | Approved | None posted |
| Dec 23, 2025 | Supplement 14Labeling · Standard review | Approved | None posted |
| Sep 30, 2025 | Supplement 12Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 13REMS | Approved | None posted |
| Dec 15, 2023 | Supplement 11Labeling · Standard review | Approved | None posted |
| Sep 10, 2021 | Supplement 10Labeling · Standard review | Approved | None posted |
| Mar 4, 2021 | Supplement 9Labeling · Standard review | Approved | None posted |
| Oct 11, 2019 | Supplement 8Labeling · Standard review | Approved | None posted |
| Sep 21, 2018 | Supplement 7Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 6REMS | Approved | None posted |
| Aug 24, 2018 | Supplement 5Labeling · Standard review | Approved | None posted |
| Aug 29, 2017 | Supplement 4Labeling · Standard review | Approved | None posted |
| Aug 21, 2017 | Supplement 3Labeling · Standard review | Approved | None posted |
| Dec 22, 2015 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters